Seer Stock Quote SEER - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

2.31

Bid

2.17

Ask

9.14

Volume

218,232

2.28 Day's Range 2.365

1.51 52 Week Range 2.625

Market Cap

136.213M

Previous Close

2.32

Open

2.29

Last Trade

2.36

Last Trade Time

Financial Volume

$ 506,957

VWAP

2.323

Average Volume (3m)

246,028

Shares Outstanding

58,966,560

Dividend Yield

PE Ratio

-1.57

Earnings Per Share (EPS)

-1.46

Revenue

16.66M

Net Profit

-86.28M

Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased... Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across the proteome. Show more

Sector

Lab Analytical Instruments

Industry

Lab Analytical Instruments

Website

www.seer.bio

Headquarters

Wilmington, Delaware, USA

Founded

Seer Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker SEER. The last closing price for Seer was $2.32. Over the last year, Seer shares have traded in a share price range of $ 1.51 to $ 2.625.

Seer currently has 58,966,560 shares outstanding. The market capitalization of Seer is $136.80 million. Seer has a price to earnings ratio (PE ratio) of -1.57.

Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

REDWOOD CITY, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced it...

Seer to Participate in Upcoming November Investor Conferences

REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Seer Reports Third Quarter 2024 Financial Results

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported...

Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced a...

Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024

REDWOOD CITY, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, will showcase the...

Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024

REDWOOD CITY, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a leading life science innovator shaping the future of proteomics, is set to present significant advancements...

Seer to Report Third Quarter 2024 Financial Results on November 6, 2024

REDWOOD CITY, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.135	-5.52147239264	2.445	2.52	2.2025	193138	2.36136884	CS
4	-0.07	-2.94117647059	2.38	2.625	2.2025	210049	2.4478365	CS
12	0.46	24.8648648649	1.85	2.625	1.82	246028	2.19344742	CS
26	0.64	38.3233532934	1.67	2.625	1.56	387932	1.87518661	CS
52	0.49	26.9230769231	1.82	2.625	1.51	425101	1.86074291	CS
156	-20.09	-89.6875	22.4	24.66	1.455	385999	5.33342826	CS
260	-45.69	-95.1875	48	86.55	1.455	413983	16.59906795	CS

SEER - Frequently Asked Questions (FAQ)

What is the current Seer share price?

The current share price of Seer is $ 2.31

How many Seer shares are in issue?

Seer has 58,966,560 shares in issue

What is the market cap of Seer?

The market capitalisation of Seer is USD 136.8M

What is the 1 year trading range for Seer share price?

Seer has traded in the range of $ 1.51 to $ 2.625 during the past year

What is the PE ratio of Seer?

The price to earnings ratio of Seer is -1.57

What is the cash to sales ratio of Seer?

The cash to sales ratio of Seer is 8.14

What is the reporting currency for Seer?

Seer reports financial results in USD

What is the latest annual turnover for Seer?

The latest annual turnover of Seer is USD 16.66M

What is the latest annual profit for Seer?

The latest annual profit of Seer is USD -86.28M

What is the registered address of Seer?

The registered address for Seer is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Seer website address?

The website address for Seer is www.seer.bio

Which industry sector does Seer operate in?

Seer operates in the LAB ANALYTICAL INSTRUMENTS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MYSZMy Size Inc	$ 4.2001 (211.12%)	120.01M
NVNINVNI Group Ltd	$ 8.26 (209.36%)	76.64M
TPICTPI Composites Inc	$ 2.45 (100.82%)	33.95M
ICGIntchains Group Ltd	$ 8.77 (88.60%)	527.61k
HSDTHelius Medical Technologies Inc	$ 0.884851 (84.34%)	120.4M
CYNCYNGN Inc	$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	$ 0.24 (65.06%)	354.32M
APTOAptose Biosciences Inc	$ 0.28 (64.51%)	305.1M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.606999 (6.49%)	292.16M
NVDANVIDIA Corporation	$ 134.70 (3.08%)	287.21M
PLTRPalantir Technologies Inc	$ 80.55 (8.54%)	277.63M